Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 42708-141

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 42708-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 141 30)

This is a medication label for Atorvastatin Calcium tablets in 20mg strength. The dosage instructions are to be found in the package insert, and the tablets are to be stored at room temperature. The container should be kept tightly closed and out of reach of children. The label suggests taking the tablet 1-2 times a day, but the exact dosage is not specified. The medication is distributed by QPharma, Inc. and is only available through prescription (Rx only).*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

This appears to be a graph showing the cumulative incidence of a medical condition or event over a period of 35 years. The two lines on the graph, labeled "Atorastatn" and "Placsbo," likely represent different treatments or groups being compared. The numbers on the y-axis indicate the percentage of people who have experienced the condition/event, while the numbers on the x-axis indicate the number of years that have passed. The HR value of 0.64 and p-value of 0.0005 suggest that there is a statistically significant difference between the two groups/treatments.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

This is a statistical data comparison between the effects of Placebo and Atorvastatin on Cumulative Hazard at a specific time frame of 4 years. Atorvastatin shows a decrease in hazard percentages compared to Placebo with a significant level of 0.001.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

This text presents the results of a study on the effects of Atorvastatin on major cardiovascular endpoints. The table shows the percentage of subjects who experienced the event, with 0.2 being the lowest percentage. Two different dosages of Atorvastatin were used, and the HR (hazard ratio) was calculated at 0.78 for the 80 mg dosage. The graph shows the time to the first major cardiovascular endpoint over a period of 4 years.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.